Close Menu

NEW YORK (GenomeWeb) – Thermo Fisher Scientific today reported an 8 percent increase in fourth quarter revenues, driven by growth across its four business segments.

The company, headquartered in Waltham, Massachusetts, reported Q4 revenues of $6.51 billion, up 8 percent from $6.05 billion in Q4 of 2017 and beating the consensus analyst estimate of $6.23 billion. Organic revenue grew 8 percent, while acquisitions drove revenue up by 1 percent and currency effects decreased revenue by 2 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News examines how science in the UK may fare as Boris Johnson, the next prime minister, pursues Brexit.

CNN reports that Immigration and Customs Enforcement in the US has expanded its DNA testing to seven sites along the southern border.

In PNAS this week: role for exosomes in neuronal circuit development, tuberculosis pathogen enzymes, and more.

Undoing Obamacare protections could affect people's willingness to undergo genetic testing, Sarah Lawrence College's Laura Hercher and the University of Iowa College of Law's Anya Prince write at BuzzFeed News.